Page last updated: 2024-11-07

n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-hydroxysuccinimidyl digoxigenin-3-O-methylcarbonyl-epsilon-aminocaproate: used to bind to catalytic alpha-subunit of the sodium pump and to cardiac glycoside receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131092
SCHEMBL ID20338627
MeSH IDM0199640

Synonyms (8)

Synonym
(2,5-dioxopyrrolidin-1-yl) 6-[[2-[[(3s,5r,8r,9s,10s,12r,13s,17r)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2h-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]acetyl]amino]hexanoate
n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate
card-20(22)-enolide, 3-(2-((6-((2,5-dioxo-1-pyrrolidinyl)oxy)-6-oxohexyl)amino)-2-oxoethoxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
129273-26-3
(3beta,5beta,12beta)-3-(2-((6-((2,5-dioxo-1-pyrrolidinyl)oxy)-6-oxohexyl)amino)-2-oxoethoxy)-12,14-dihydroxycard-20(22)-enolide
SCHEMBL20338627
DTXSID50926362
3-[2-({6-[(2,5-dioxopyrrolidin-1-yl)oxy]-6-oxohexyl}imino)-2-hydroxyethoxy]-12,14-dihydroxycard-20(22)-enolide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (50.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's4 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.79 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (10.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]